Literature DB >> 6832194

Modelling of initial distribution of drugs following intravenous bolus injection.

M Weiss.   

Abstract

Based on a recirculatory pharmacokinetic model, a physiologically realistic definition of the initial distribution volume has been developed to characterize the overall distribution process occurring shortly after rapid bolus injection of a drug. This apparent volume of distribution, which refers to the peak right atrial blood concentration, depends on the cardiac output and basic pharmacokinetic parameters usually derived from the whole blood concentration vs time curve. The initial distribution process appears to be affected by changes in the variance of the distribution of residence times of the drug in the body. The influence of the site and time of early blood sampling on the estimated initial distribution volume is discussed. This relatively simple a priori model should prove useful in predicting to a first approximation the principal characteristics of the initial distribution process.

Mesh:

Substances:

Year:  1983        PMID: 6832194     DOI: 10.1007/bf00613938

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

1.  Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans.

Authors:  P H Hinderling; E R Garrett
Journal:  J Pharmacokinet Biopharm       Date:  1976-06

2.  A unified theory for estimation of cardiac output, volumes of distribution and renal clearance from indicator dilution curves.

Authors:  L D Homer; A Small
Journal:  J Theor Biol       Date:  1977-02-07       Impact factor: 2.691

3.  A linear recirculation model for drug disposition.

Authors:  D J Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

4.  Hemodynamic influences upon the variance of disposition residence time distribution of drugs.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1983-02

5.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

6.  Residence time and accumulation of drugs in the body.

Authors:  M Weiss
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1981-02

7.  Potential effect of early blood sampling schedule on calculated pharmacokinetic parameters of drugs after intravenous administration.

Authors:  W L Chiou
Journal:  J Pharm Sci       Date:  1980-07       Impact factor: 3.534

8.  Comparison of the pharmacokinetics of intravenous dl-propranolol in borderline and permanent hypertension.

Authors:  Y A Weiss; M E Safar; C Chevillard; A Frydman; A Simon; P Lemaire; J M Alexandre
Journal:  Eur J Clin Pharmacol       Date:  1976       Impact factor: 2.953

9.  Pharmacokinetics of beta-methyldigoxin in healthy humans I: intravenous studies.

Authors:  P H Hinderling; E R Garrett; R D Wester
Journal:  J Pharm Sci       Date:  1977-02       Impact factor: 3.534

10.  Arterial-venous plasma concentration differences of six drugs in the dog and rabbit after intravenous administration.

Authors:  W L Chiou; G Lam; M L Chen; M G Lee
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1981-04
View more
  11 in total

Review 1.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

2.  A note on population analysis of dissolution-absorption models using the inverse Gaussian function.

Authors:  Jian Wang; Michael Weiss; David Z D'Argenio
Journal:  J Clin Pharmacol       Date:  2008-03-21       Impact factor: 3.126

3.  Pharmacokinetics from a dynamical systems point of view.

Authors:  J M van Rossum; J E de Bie; G van Lingen; H W Teeuwen
Journal:  J Pharmacokinet Biopharm       Date:  1989-06

4.  A non-Markovian model for calcium kinetics in the body.

Authors:  G H Weiss; R E Goans; M Gitterman; S A Abrams; N E Vieira; A L Yergey
Journal:  J Pharmacokinet Biopharm       Date:  1994-10

5.  Use of gamma distributed residence times in pharmacokinetics.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  A note on the rôle of generalized inverse Gaussian distributions of circulatory transit times in pharmacokinetics.

Authors:  M Weiss
Journal:  J Math Biol       Date:  1984       Impact factor: 2.259

7.  Hemodynamic influences upon the variance of disposition residence time distribution of drugs.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1983-02

8.  Negative power functions of time in pharmacokinetics and their implications.

Authors:  M E Wise
Journal:  J Pharmacokinet Biopharm       Date:  1985-06

9.  Pharmacokinetics and electrophysiological effects of intravenous ajmaline.

Authors:  R Padrini; D Piovan; A Javarnaro; F Cucchini; M Ferrari
Journal:  Clin Pharmacokinet       Date:  1993-11       Impact factor: 6.447

10.  Applications of minimal physiologically-based pharmacokinetic models.

Authors:  Yanguang Cao; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-11-23       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.